Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NEFM | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | WDR61 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
mRNA | INPP5J | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | FAAH | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | FAHD2A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | GPR63 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | BCDIN3D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | ZNF33A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | CNTD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | ULK2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |